BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 15900325)

  • 21. Sialic acid and N-acyl sialic acid analog production by fermentation of metabolically and genetically engineered Escherichia coli.
    Lundgren BR; Boddy CN
    Org Biomol Chem; 2007 Jun; 5(12):1903-9. PubMed ID: 17551639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of isotopically radiolabelled GM3 ganglioside to study metabolic alterations in Salla disease.
    Chigorno V; Valsecchi M; Nicolini M; Sonnino S
    Indian J Biochem Biophys; 1997; 34(1-2):150-6. PubMed ID: 9343943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycomimicry: display of the GM3 sugar epitope on Escherichia coli and Salmonella enterica sv Typhimurium.
    Ilg K; Yavuz E; Maffioli C; Priem B; Aebi M
    Glycobiology; 2010 Oct; 20(10):1289-97. PubMed ID: 20574043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative analysis of the molecular species of monosialogangliosides by continuous-flow fast-atom bombardment mass spectrometry.
    Chen S; Pieraccini G; Moneti G
    Rapid Commun Mass Spectrom; 1991 Dec; 5(12):618-21. PubMed ID: 1811797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psathyrella velutina lectin as a specific probe for N-acetylneuraminic acid in glycoconjugates.
    Ueda H; Takahashi N; Ogawa H
    Methods Enzymol; 2003; 363():77-90. PubMed ID: 14579568
    [No Abstract]   [Full Text] [Related]  

  • 26. Cell growth arrest by sialic acid clusters in ganglioside GM3 mimetic polymers.
    Uemura S; Feng F; Kume M; Yamada K; Kabayama K; Nishimura S; Igarashi Y; Inokuchi J
    Glycobiology; 2007 Jun; 17(6):568-77. PubMed ID: 17317719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluorescent labeling of a carboxyl group of sialic acid for MALDI-MS analysis of sialyloligosaccharides and ganglioside.
    Endo S; Morita M; Ueno M; Maeda T; Terabayashi T
    Biochem Biophys Res Commun; 2009 Jan; 378(4):890-4. PubMed ID: 19070600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of a melanoma-specific antibody response by a monovalent, but not a divalent, synthetic GM2 neoglycopeptide.
    Bay S; Fort S; Birikaki L; Ganneau C; Samain E; Coïc YM; Bonhomme F; Dériaud E; Leclerc C; Lo-Man R
    ChemMedChem; 2009 Apr; 4(4):582-7. PubMed ID: 19226501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence supporting a late Golgi location for lactosylceramide to ganglioside GM3 conversion.
    Allende ML; Li J; Darling DS; Worth CA; Young WW
    Glycobiology; 2000 Oct; 10(10):1025-32. PubMed ID: 11030748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluorous-tagged compound: a viable scaffold to prime oligosaccharide synthesis by cellular enzymes.
    Kasuya MC; Cusi R; Ishihara O; Miyagawa A; Hashimoto K; Sato T; Hatanaka K
    Biochem Biophys Res Commun; 2004 Apr; 316(3):599-604. PubMed ID: 15033442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Solution conformations of GM3 gangliosides containing different sialic acid residues as revealed by NOE-based distance mapping, molecular mechanics, and molecular dynamics calculations.
    Siebert HC; Reuter G; Schauer R; von der Lieth CW; Dabrowski J
    Biochemistry; 1992 Aug; 31(30):6962-71. PubMed ID: 1637830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A combined NMR, MD and DFT conformational analysis of 9-O-acetyl sialic acid-containing GM3 ganglioside glycan and its 9-N-acetyl mimic.
    Li W; Battistel MD; Reeves H; Oh L; Yu H; Chen X; Wang LP; Freedberg DI
    Glycobiology; 2020 Sep; 30(10):787-801. PubMed ID: 32350512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of ganglioside GM3 and analogs containing modified sialic acids and ceramides.
    Kiso M; Hasegawa A
    Methods Enzymol; 1994; 242():173-83. PubMed ID: 7891575
    [No Abstract]   [Full Text] [Related]  

  • 34. Microbial production of N-acetylneuraminic acid by genetically engineered Escherichia coli.
    Ishikawa M; Koizumi S
    Carbohydr Res; 2010 Dec; 345(18):2605-9. PubMed ID: 20971455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficient synthesis of a sialic acid alpha(2-->3)galactose building block and its application to the synthesis of ganglioside GM3.
    Liu Y; Ruan X; Li X; Li Y
    J Org Chem; 2008 Jun; 73(11):4287-90. PubMed ID: 18433175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biosynthesis of glycosphingolipids in cultured mouse neuroblastoma cells. Precursor-product relationships among sialoglycosphingolipids.
    Kemp SF; Stoolmiller AC
    J Biol Chem; 1976 Dec; 251(23):7626-31. PubMed ID: 1033935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant ganglioside GM2 synthase--expression in insect cells and enzyme assay.
    Wendeler M; Reilaender H; Hoernschemeyer J; Schwarzmann G; Kolter T; Sandhoff K
    Methods Enzymol; 2003; 363():476-89. PubMed ID: 14579597
    [No Abstract]   [Full Text] [Related]  

  • 38. The oligosaccharidic content of the glycoconjugates of the prepubertal descended and undescended testis: lectin histochemical study.
    Gheri G; Sgambati E; Thyrion GD; Vichi D; Orlandini GE
    Ital J Anat Embryol; 2004; 109(2):69-84. PubMed ID: 15481156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ganglioside composition and biosynthesis in cultred cells derived from CNS.
    Duffard RO; Fishman PH; Bradley RM; Lauter CJ; Brady RO; Trams EG
    J Neurochem; 1977 Jun; 28(6):1161-6. PubMed ID: 406360
    [No Abstract]   [Full Text] [Related]  

  • 40. Chemoenzymatic Syntheses of Sialylated Oligosaccharides Containing C5-Modified Neuraminic Acids for Dual Inhibition of Hemagglutinins and Neuraminidases.
    Birikaki L; Pradeau S; Armand S; Priem B; Márquez-Domínguez L; Reyes-Leyva J; Santos-López G; Samain E; Driguez H; Fort S
    Chemistry; 2015 Jul; 21(30):10903-12. PubMed ID: 26088695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.